MUC16 and ovarian cancer: Reflecting the issue of CKD-induced increase of serum HE4 levels, Kappelmayer et al. proposed an algorithm for the prediction of ovarian cancer that uses eGFR, serum HE4, and CA125 levels - regardless of the menopause status - in patients who suffer from kidney disorders [35].